| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9312050 | Urology | 2005 | 6 Pages |
Abstract
Our data have indicated that celecoxib and indomethacin inhibit PG release by the ureter to a similar degree, even in the presence of COX-2 induction. Animal experiments and clinical trials evaluating the safety and efficacy of celecoxib for the treatment of symptomatic ureteral obstruction are warranted.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Travis J. Jerde, Jamie L. Calamon-Dixon, Dale E. Bjorling, Stephen Y. Nakada,